Crescent Biopharma, Inc. (CBIO)
Track the next or latest earnings date for Crescent Biopharma, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
investing.com · 1 day ago
Clover Health Medicare Advantage CEO Reynoso sells $32,764 in stock
Cincinnati Financial stock hits all-time high at 192.6 USD By Investing.comca.investing.com · 6 hours ago
Cincinnati Financial stock hits all-time high at 192.6 USD
Cboe Global Markets reports record June trading volumes By Investing.cominvesting.com · 1 day ago
The declining revenue per contract aligns with analyst expectations of a slight sales decline for the current year. Despite this, Cboe maintains strong profitability with a 54% gross margin and diluted earnings of $11.71 per share over the last twelve months. InvestingPro data suggests the stock is …
Unpacking Q4 Earnings: CVB Financial (NASDAQ:CVBF) In The Context Of Other Regional Banks Stocksfinance.yahoo.com · 3 hours ago
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how regional banks stocks fared in Q4, starting with CVB Financial (NASDAQ:CVBF).
What You Need To Know Ahead of Cincinnati Financial’s Earnings Releasefinance.yahoo.com · 5 days ago
Cincinnati Financial will release its second-quarter earnings later this month, and analysts anticipate its EPS to dip by a low double-digit percentage from a year ago.
Latest earnings date
Time not specified
Fiscal quarter: Dec/2025
EPS estimate: -$1.78
Revenue estimate: N/A
Market cap: $260.41M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 12, 2026 | Dec/2025 | Time not specified | -$1.78 | N/A |